公司资料
Materialise 股价、新闻与催化剂
- 股票代码:
- MTLS
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- Belgium
股票表现
6.73 USD (-2.75%)
收盘价
最后更新: 2026年8月17日
401M USD
市值
股价为何变动
As of Aug 17, 2026, MTLS closed down 2.75% at $6.73. No new same-company headline was identified in the current news window.
公司概览
Additive-Manufacturing Technology
Materialise is a global 3D-printing company providing software, production services and medical applications. Its technology supports the design and manufacture of complex parts from digital models.
Medical Solutions
The medical segment develops patient-specific surgical planning tools, anatomical models, implants and other 3D-printed devices used by clinicians and medical-device companies.
Manufacturing Software
Materialise sells software used to prepare, manage and optimize additive-manufacturing workflows across industrial and healthcare customers.
Production Services
The company also manufactures prototypes and end-use parts for customers that require additive-manufacturing capacity without operating their own production infrastructure.
未来催化剂
- Materialise's catalysts are 3D-printing adoption, orthopedic software, and medical-application demand. The company benefits when clinical and industrial demand both stay healthy.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。